June 27 (Reuters) - Daiichi Sankyo Co 4568.T
* Daiichi Sankyo Co Ltd says has entered into an agreement
with Servier Canada
* Agreement in which Servier Canada will market oral,
once-daily anti-coagulant edoxaban in Canada, if approved by
Canadian Health Authority
* Daiichi Sankyo Co Ltd says further financial details are
not being disclosed
* Co will receive an upfront payment, payments based on
regulatory and commercial milestones, as well as royalties on
net product sales
Source text for Eikon: ID:nCNWKVbzCa
Further company coverage: 4568.T
(Bengaluru Newsroom: +1 646 223 8780)